Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
Meng‐Ju Wu, Hiroshi Kondo, Ashwin V. Kammula, et al.
Science (2024) Vol. 385, Iss. 6705
Closed Access | Times Cited: 15

Showing 15 citing articles:

Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets
Jean‐Ehrland Ricci
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115206-115206
Closed Access | Times Cited: 2
IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
Alexander W. Bray, Vaibhav Sahai
Current Oncology (2025) Vol. 32, Iss. 1, pp. 44-44
Open Access
Fine-tuning tumor immunogenicity with mitochondrial complex I
Désirée Schatton, Christian Frezza
Nature Cancer (2025)
Closed Access
IDHIRA: a prospective, observational study on ivosidenib in patients with IDH1 R132-mutated advanced cholangiocarcinoma
Marlies Michl, Nora Hagemeyer, M. Looß, et al.
Future Oncology (2025), pp. 1-8
Open Access
Cell competition as an emerging mechanism and therapeutic target in cancer
Dakai Yang, Wenyue Sun, Lu Gao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167769-167769
Closed Access
KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells
Lena Lau, Kurt Henderson, Ahu Turkoz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer
Letizia Lanzetti
Cell Death and Differentiation (2024)
Open Access | Times Cited: 3
Co-evolution of glioma and immune microenvironment
Mahmoud Elguindy, Jacob S. Young, Winson S. Ho, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009175-e009175
Open Access | Times Cited: 2
Unmasking immune suppression
Jason R. Pitarresi, Katherine A. Fitzgerald
Science (2024) Vol. 385, Iss. 6705, pp. 140-142
Closed Access | Times Cited: 1
Cholangiocarcinoma Targeted Therapies: Mechanisms of Action and Resistance
Haley Ellis, Chiara Braconi, Juan W. Valle, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 1
Breathing new life into in vivo lung editing

Nature Biotechnology (2024) Vol. 42, Iss. 7, pp. 993-994
Closed Access
Advances in brain tumor therapy: from molecular diagnostics to novel treatments
Junwen Zhang, Ran Mu, Fusheng Liu
Science China Life Sciences (2024)
Closed Access
Human stem cell-specific epigenetic signatures control transgene expression
Chulhwan Kwak, Furkan E. Oflaz, Jiamin Qiu, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2024), pp. 195063-195063
Closed Access
Heating Up IDH-Mutant Gliomas
Michael Platten, Lukas Bunse
New England Journal of Medicine (2024) Vol. 391, Iss. 22, pp. 2170-2172
Closed Access
Controlling and controlled elements: highlights of the year in mobile DNA research
Irina R. Arkhipova, Kathleen H. Burns, Pascale Lesage
Mobile DNA (2024) Vol. 15, Iss. 1
Open Access
Page 1

Scroll to top